557 — China Tian Yuan Healthcare Income Statement
0.000.00%
- HK$319.18m
- HK$314.34m
- HK$26.85m
Annual income statement for China Tian Yuan Healthcare, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 56.3 | 94.6 | 54.2 | 45.2 | 26.8 |
Cost of Revenue | |||||
Gross Profit | 37.6 | 71.3 | 34.8 | 27.9 | 21.2 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 180 | 109 | 90.8 | 70.1 | 62 |
Operating Profit | -124 | -14.8 | -36.6 | -24.9 | -35.2 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -126 | -19.1 | -40.3 | -28.8 | -38.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -110 | -19.1 | -40.3 | -27 | -38.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -65.1 | -16.9 | -29 | -15.5 | -34.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -65.1 | -16.9 | -29 | -15.5 | -34.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.032 | -0.042 | -0.067 | -0.036 | -0.052 |